A first look at the Oxford Nanopore MinION sequencer

Abstract

Oxford Nanopore's third-generation single-molecule sequencing platform promises to decrease costs for reagents and instrumentation. After a 2-year hiatus following the initial announcement, the first devices have been released as part of an early access program. We explore the performance of this platform by resequencing the lambda phage genome, and amplicons from a snake venom gland transcriptome. Although the handheld MinION sequencer can generate more than 150 megabases of raw data in one run, at most a quarter of the resulting reads map to the reference, with less than average 10% identity. Much of the sequence consists of insertion/deletion errors, or is seemingly without similarity to the template. Using the lambda phage data as an example, although the reads are long, averaging 5 kb, at best 890 ± 1932 bases per mapped read could be matched to the reference without soft clipping. In the course of a 36 h run on the MinION, it was possible to resequence the 48 kb lambda phage reference at 16× coverage. Currently, substantially larger projects would not be feasible using the MinION. Without increases in accuracy, which would be required for applications such as genome scaffolding and phasing, the current utility of the MinION appears limited. Library preparation requires access to a molecular laboratory, and is of similar complexity and cost to that of other next-generation sequencing platforms. The MinION is an exciting step in a new direction for single-molecule sequencing, though it will require dramatic decreases in error rates before it lives up to its promise.

Blood transcriptome changes after stroke in an African American population

“…However, the current approach may yield panels of genes that could be utilized for more rapid technological platforms, such as qPCR. Faster electrode‐based sequencing systems are on the horizon27 and show much promise for the speeding up of the transcriptome analysis process, which may make this approach suitable for point of care use in the future. An alternative will be the development of a rapid PCR‐based multiplex assay, which can be performed and analyzed rapidly (>1 h).…”

Graphene nanodevices for DNA sequencing

“…Another interesting innovation recently emerged from Oxford Nanopore Technologies that built a sequencing device based on biological nanopores [11]. In such nanopore sequencing, one detects the base-dependent changes in the ionic current while a DNA molecule passes through the pore.…”

The emergence of nanopores in next-generation sequencing

“…Oxford Nanopore Technologies (ONT) is developing a device based on an array of biological nanopores as described in figures 3(a) and (b) and launched a beta test at the beginning of this year [22]. A commercial launch has not yet been disclosed, but if the technology is coupled with a device that enables reliable decoding of long sequences with an acceptable error rate, it could change the current landscape of DNA sequencing.…”